Claro Patent Expiration

Exclusivity Information

Claro holds 1 exclusivity out of which 1 has expired. Details of Claro's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Sep 20, 2018

About Claro

Claro is a drug owned by ELANCO US INC. Claro uses Florfenicol, Mometasone Furoate, Terbinafine as the active ingredients.

Active Ingredient:

Claro uses Florfenicol, Mometasone Furoate, Terbinafine as the active ingredients. Check out other Drugs and Companies using Florfenicol, Mometasone Furoate, Terbinafine ingredient.